Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00017537
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

Who this might be right for
Breast CancerGastric CancerLung Cancer+2 more
University of Alabama at Birmingham
Not applicableStudy completedNCT01858688
What this trial is testing

A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 101
Testing effectiveness (Phase 2)Ended earlyNCT03316222
What this trial is testing

Study of GNS561 in Patients With Liver Cancer

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinoma, Intrahepatic
Genoscience Pharma 50
Not applicableStudy completedNCT07151469
What this trial is testing

Kaltenborn Versus Active Release on Temporomandibular Joint Dysfunction

Who this might be right for
Head and Neck Cancer
MTI University 115
Testing effectiveness (Phase 2)Looking for participantsNCT06427941
What this trial is testing

BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines 630
Not applicableStudy completedNCT02567929
What this trial is testing

Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer

Who this might be right for
Breast Cancer
Konkuk University Medical Center 218
Testing effectiveness (Phase 2)Study completedNCT01243073
What this trial is testing

Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera

Who this might be right for
Essential ThrombocythemiaPolycythemia Vera
Geron Corporation 20
Early research (Phase 1)Study completedNCT01523353
What this trial is testing

Prehabilitation in Liver Surgery

Who this might be right for
Colorectal CancerColorectal Liver MetastasisLiver Surgery+1 more
Liverpool University Hospitals NHS Foundation Trust 37
Testing effectiveness (Phase 2)WithdrawnNCT02545361
What this trial is testing

Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients

Who this might be right for
Lymphoma
Kahr Medical
Testing effectiveness (Phase 2)Looking for participantsNCT07567846
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

Who this might be right for
Advanced Prostate CancerMetastatic Prostate Cancer
Genentech, Inc. 260
Not applicableStudy completedNCT03290417
What this trial is testing

Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 37
Not applicableEnded earlyNCT01890824
What this trial is testing

Fat Metabolism Following Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Texas A&M University 5
Early research (Phase 1)Ended earlyNCT03451825
What this trial is testing

Phase I/II Study of Avelumab in Pediatric Cancer Participants

Who this might be right for
Refractory or Relapsed Solid TumorsLymphoma
EMD Serono Research & Development Institute, Inc. 21
Early research (Phase 1)Study completedNCT04306224
What this trial is testing

IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas

Who this might be right for
Solid TumorLymphoma
ImmuneOncia Therapeutics Inc. 12
Not applicableLooking for participantsNCT07704476
What this trial is testing

EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

Who this might be right for
CancerBreast Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 40
Testing effectiveness (Phase 2)Study completedNCT03752723
What this trial is testing

Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)

Who this might be right for
Triple Negative Breast Cancer
Genexine, Inc. 84
Early research (Phase 1)Study completedNCT01333046
What this trial is testing

Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaHodgkin Disease
Baylor College of Medicine 36
Not applicableStudy completedNCT05604235
What this trial is testing

Effectiveness of Oncological Physiotherapy on Painful Shoulder Cervical Ganglion in Head and Neck Cancer

Who this might be right for
CancerShoulder PainRehabilitation
University of Alcala 20
Not applicableStudy completedNCT02341235
What this trial is testing

Self-monitoring Activity: a Randomized Trial of Game-oriented Applications

Who this might be right for
Breast CancerObesity
The University of Texas Medical Branch, Galveston 90
Not applicableStudy completedNCT02627235
What this trial is testing

The Deep South IVR-based Active Lifestyle Study

Who this might be right for
Physical Activity
University of Alabama at Birmingham 62
Next Page